1. Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin.

2. Vitiligo: successful combination treatment based on oral low dose cytokines and different topical treatments.

3. Non-healing facial lesions: cutaneous old world leishmaniasis in dresden.

4. Ulcerated cutaneous myeloid sarcoma associated with myelodysplastic syndrome.

5. Nonsyndromic aplasia cutis congenita: a case report.

6. Giant congenital melanocytic nevus localized in the axillary area: serial excisions as optimal treatment option.

7. Intralymphatic histiocytosis overlying hip implantation treated with pentoxifilline.

8. Neglected giant spinocellular carcinoma of the lower lip.

9. NEVUS DEPIGMENTOSUS ASSOCIATED WITH NEVUS SPILUS: FIRST REPORT IN THE WORLD LITERATURE.

10. The "different face" of esophageal cancer: cutaneous manifestation of visceral malignancies.

11. [Successful combination treatment for psoriasis with phototherapy and low-dose cytokines: A spontaneous, retrospective observational clinical study].

12. TOPICAL CORTICOSTEROIDS BUT NOT CALCINEURIN INHIBITORS INDUCED ATROPHY AFTER FOUR WEEKS.

13. IMP-3 EXPRESSION IN BENIGN MELANOCYTIC NEVI, DYSPLASTIC NEVI AND MALIGNANT MELANOMA: PRELIMINARY FINDINGS IN BULGARIAN PATIENTS.

14. Advances in the treatment options for vitiligo: activated low-dose cytokines-based therapy.

15. Impact of HER2 codon 655 polymorphism and expression of HER2 and HER3 in non small cell lung cancer patients.

16. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.

17. Faster through training: The anammox case.

18. Heel melanoma: the final result of wrong diagnostic and therapeutic approach in another bulgarian patient. First documented case from the board of the “adcrstr-association for dermatohistopathologic control, reevaluation and subsequent therapeutic recomme.

19. Polyamide hair implant (biofibre®): evaluation of efficacy and safety in a group of 133 patients.

20. A case of perforating folliculitis in association with antisynthetase syndrome.

21. Vascular neoplasm or pseudovascular nevus? Potential pitfalls in diagnosis.

22. Dysplastic nevi, melanoma and pregnancy- where is the relationship?

23. Basal cell carcinoma or not Basal cell carcinoma? That is the question!

24. “Melanoma imitators”- how to prevent the aggressive approach?

25. Melanoma of the heel – a case series of a rare melanoma subtype.

26. Are microscopic satellites in melanoma indicative of lymphovascular invasion? A preliminary case study.

27. Desmoplastic malignant melanoma associated with pigmented ocular tumor: second documented problematic case from the board of “adcrstr-association for dermatohistopathologic control, re-evaluation and subsequent therapeutic recommendations”.

28. Treating skin diseases according to the low dose medicine principles. Data and hypotheses.

29. Psycho-neuro-endocrine-immunology and low dose cytokines therapy: principles and evidences for an innovative medical approach in acute and chronic inflammatory diseases.

30. Sarcoid type reaction: medical hypotheses.

31. Sarcoid sine sarcoidosis? A classificative, semantic and therapeutic dilemma.

32. Life-threatening onychomycosis imitator.

33. Foot ulcers in klippel-trenaunay syndrome: two case reports and one metatypical Basal cell carcinoma.

34. Nodular epitheloid sarcoma of the upper limb. A case report and review of the literature.

35. Schnitzler syndrome responding to interleukin-1 antagonist anakinra.

36. Generalized eruptive histiocytoma in adult patient.

37. Failure of vismodegib in advanced Basal cell carcinoma.

38. Sarcoidosis exclusion criteria: the “simple truth” for a “complicated diagnosis”.

39. Acute overnight painful swelling of a finger.

40. High frequency ultrasonography of the skin and its role as an auxillary tool in diagnosis of benign and malignant cutaneous tumors--a comparison of two clinical cases.

41. Coexistence of pemphigus foliaceus and acquired hemophilia A: A case report.

42. Vulvar sarcomas: Short guideline for histopathological recognition and clinical management. Part 1.

43. Vulvar sarcomas: Short guideline for histopathological recognition and clinical management. Part 2.

44. Correlation of Serum Thyroid Hormones Autoantibodies with Self-Reported Exposure to Thyroid Disruptors in a Group of Nonsegmental Vitiligo Patients.

45. Pilot-scale evaluation of anammox-based mainstream nitrogen removal from municipal wastewater.

46. Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry.

47. Bacterial community structure of a lab-scale anammox membrane bioreactor.

48. Efficacy, tolerability and safety of switching from etanercept to infliximab for the treatment of moderate-to-severe psoriasis: A multicenter, open-label trial (TANGO).

49. First case of pachyonychia congenita in the Czech Republic.

50. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.

51. Effect of temperature change on anammox activity.

52. Increased serum level of N-terminal Pro-B-type natriuretic peptide as a possible biomarker of cardiovascular risk in psoriatic patients.
    dermatologo

PUBLICATIONS